PIA
TEVA icon

Philadelphia International Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Philadelphia International Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$17.9M Buy
286,661
+114,459
+66% +$6.65M 7.46% 1
2014
Q4 		$9.9M Sell
172,202
-4,351
-2% -$242K 2.95% 1
2014
Q3 		$9.49M Buy
+176,553
New +$9.35M 2.44% 4
2013
Q4 		– Sell
-286,805
Closed -$10.8M – 88
2013
Q3 		$10.8M Sell
286,805
-555,591
-66% -$21.7M 2.45% 4
2013
Q2 		$33M Buy
+842,396
New +$32.8M 7.43% 1

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Philadelphia International Advisors's TEVA Position: Q1 2015 in Review

Philadelphia International Advisors increased its Teva Pharmaceuticals (TEVA) stake by 66% in Q1 2015, buying an estimated $6.65M and bringing the position to 286,661 shares worth $17.9M. The position accounts for 7.46% of the portfolio, ranked #1.

Philadelphia International Advisors first reported a position in TEVA in Q2 2013 and has held it in 5 quarters since. The position peaked at $33M in Q2 2013. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Philadelphia International Advisors held 286,661 shares of Teva Pharmaceuticals worth $17.9M as of Q1 2015.
  • Philadelphia International Advisors bought 114,459 Teva Pharmaceuticals shares in Q1 2015, an estimated $6.65M.
  • Teva Pharmaceuticals made up 7.46% of Philadelphia International Advisors's portfolio in Q1 2015, its #1 holding.
  • Philadelphia International Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
  • Philadelphia International Advisors's Teva Pharmaceuticals position peaked at $33M in Q2 2013.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Philadelphia International Advisors's 13F filing for Q1 2015, filed 29 Apr 2015.